119 related articles for article (PubMed ID: 8047846)
21. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
Medof ME; Prince GM; Oger JJ
Clin Exp Immunol; 1982 Jun; 48(3):715-25. PubMed ID: 7116690
[TBL] [Abstract][Full Text] [Related]
22. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
Kávai M; Rasmussen JM; Baatrup G; Zsindely A; Svehag SE
Scand J Immunol; 1988 Jul; 28(1):123-8. PubMed ID: 2969612
[TBL] [Abstract][Full Text] [Related]
23. Another function of erythrocytes: transport of circulating immune complexes.
Pascual M; Schifferli JA
Infusionsther Transfusionsmed; 1995 Oct; 22(5):310-5. PubMed ID: 8924746
[TBL] [Abstract][Full Text] [Related]
24. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
[TBL] [Abstract][Full Text] [Related]
25. Complement mediates the binding of HIV to erythrocytes.
Horakova E; Gasser O; Sadallah S; Inal JM; Bourgeois G; Ziekau I; Klimkait T; Schifferli JA
J Immunol; 2004 Sep; 173(6):4236-41. PubMed ID: 15356175
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood mononuclear leukocytes release a mediator(s) that induces phagocytosis of C-reactive protein-coated cells by polymorphonuclear leukocytes.
Kilpatrick JM; Gresham HD; Griffin FM; Volanakis JE
J Leukoc Biol; 1987 Feb; 41(2):150-5. PubMed ID: 3543183
[TBL] [Abstract][Full Text] [Related]
27. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.
Bredius RG; Fijen CA; De Haas M; Kuijper EJ; Weening RS; Van de Winkel JG; Out TA
Immunology; 1994 Dec; 83(4):624-30. PubMed ID: 7875742
[TBL] [Abstract][Full Text] [Related]
28. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
[TBL] [Abstract][Full Text] [Related]
29. Human erythrocytes inhibit complement-mediated solubilization of immune complexes.
Dorval BL; Cosio FG; Birmingham DJ; Hebert LA
J Immunol; 1989 Apr; 142(8):2721-7. PubMed ID: 2522967
[TBL] [Abstract][Full Text] [Related]
30. Exposure to complement-bearing immune complexes enhances the in vitro sequestration of erythrocytes from young but not elderly donors.
Shapiro S; Pilar T; Gershon H
Clin Exp Immunol; 1993 Feb; 91(2):301-7. PubMed ID: 8428395
[TBL] [Abstract][Full Text] [Related]
31. Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1).
Imrie HJ; Jones DR
Clin Exp Immunol; 1997 Jul; 109(1):217-22. PubMed ID: 9218847
[TBL] [Abstract][Full Text] [Related]
32. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
Pascual M; Schifferli JA
Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
[TBL] [Abstract][Full Text] [Related]
33. CR1 and CR1-like: the primate immune adherence receptors.
Birmingham DJ; Hebert LA
Immunol Rev; 2001 Apr; 180():100-11. PubMed ID: 11414352
[TBL] [Abstract][Full Text] [Related]
34. Immune complex-stimulated neutrophil LTB4 production is dependent on beta 2 integrins.
Graham IL; Lefkowith JB; Anderson DC; Brown EJ
J Cell Biol; 1993 Mar; 120(6):1509-17. PubMed ID: 8383692
[TBL] [Abstract][Full Text] [Related]
35. BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.
Varga L; Thiry E; Füst G
Immunology; 1988 Jul; 64(3):381-4. PubMed ID: 3410490
[TBL] [Abstract][Full Text] [Related]
36. A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes.
Oudin S; Libyh MT; Goossens D; Dervillez X; Philbert F; Réveil B; Bougy F; Tabary T; Rouger P; Klatzmann D; Cohen JH
J Immunol; 2000 Feb; 164(3):1505-13. PubMed ID: 10640768
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates.
Cosio FG; Shen XP; Birmingham DJ; Van Aman M; Hebert LA
J Immunol; 1990 Dec; 145(12):4198-206. PubMed ID: 2147938
[TBL] [Abstract][Full Text] [Related]
38. Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization.
Fernandez-Arias C; Lopez JP; Hernandez-Perez JN; Bautista-Ojeda MD; Branch O; Rodriguez A
J Immunol; 2013 Apr; 190(7):3363-72. PubMed ID: 23440418
[TBL] [Abstract][Full Text] [Related]
39. An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors.
Graham IL; Gresham HD; Brown EJ
J Immunol; 1989 Apr; 142(7):2352-8. PubMed ID: 2538507
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.
Emlen W; Carl V; Burdick G
Clin Exp Immunol; 1992 Jul; 89(1):8-17. PubMed ID: 1385769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
